[Management of spondyloarthritis].

Management of spondyloarthritis. Management of spondyloarthritis is based on early diagnosis, patient information and education, a tight control of disease activity, screening and treatment of comorbidities, physiotherapy in axial forms, and the use of various drugs. Non-steroidal anti-inflammatory drugs remain the first line therapy, used in an "on demand" strategy. If unsuccessful, biological drugs (antiTNFá or anti-Il17) can be considered in axial forms, and in peripheral forms a chemical DMARD such as methotrexate should be used. In case of failure of this DMARD, and if associated psoriasis, biological drugs (antiTNFá or anti-Il17 or anti-Il12/Il23), and in some cases aprémilast, should be considered.